Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,472
datasets available to search
ShareScore release 0.9.0
Dataset results
1,472 results for “EGFR”
Erlotinib in Patients With Resected, Early Stage NSCLC With Confirmed Mutations in the EGFR
ClinicalTrials.gov study NCT00567359. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Rapid Plasma Genotyping For Early Initiation Of Erlotinib In EGFR Mutant Lung Cancer
ClinicalTrials.gov study NCT02770014. IPD Sharing: NO. Countries: 1. Publications: 0.
A Phase 2, Study of Ficlatuzumab Plus Erlotinib vs. Placebo Plus Erlotinib in Subjects With Previously Untreated Metastatic, EGFR-mutated NSCLC and BDX004 Positive Label
ClinicalTrials.gov study NCT02318368. IPD Sharing: NO. Countries: 7. Publications: 0.
TIGER-3: Open Label, Multicenter Study of Rociletinib (CO-1686) Mono Therapy Versus Single-agent Cytotoxic Chemotherapy in Patients With Mutant EGFR NSCLC Who Have Failed at Least One Previous EGFR-Di
ClinicalTrials.gov study NCT02322281. IPD Sharing: Not stated. Countries: 10. Publications: 0.
Afatinib and Vinorelbine in Tumours Known to Overexpress EGFR and/or HER2
ClinicalTrials.gov study NCT00906698. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Local Therapies for Oligometastatic Non-Small Cell Lung Cancer Harboring Sensitizing EGFR Mutations
ClinicalTrials.gov study NCT02450591. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase 1b/2 Study of Safety and Efficacy of Rociletinib in Combination With MPDL3280A in Patients With Advanced or Metastatic EGFR-mutant NSCLC
ClinicalTrials.gov study NCT02630186. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Effect of Direct AntiViral Drugs of Chronic HCV on eGFR in Assuit Universiry Hospital
ClinicalTrials.gov study NCT03965286. IPD Sharing: Not stated. Countries: 0. Publications: 3.
Asia Pacific and Russia Diagnostic Study for EGFR Testing
ClinicalTrials.gov study NCT01788163. IPD Sharing: Not stated. Countries: 9. Publications: 0.
Trial of Ruxolitinib and Erlotinib in Patients With EGFR-mutant Lung Adenocarcinoma With Acquired Resistance to Erlotinib
ClinicalTrials.gov study NCT02155465. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Afatinib in EGFR+NSCLC (Recurrent or Stage IV) - Patients With Poor Performance Status (ECOG 2 or 3)
ClinicalTrials.gov study NCT02695290. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Efficacy of PF-299804 (Dacomitinib), a Pan-HER Irreversible Inhibitor, in Patients With Recurrent Glioblastoma With EGFR Amplification or Presence of EGFRvIII Mutation. A Phase II CT.
ClinicalTrials.gov study NCT01520870. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Nivolumab in Combination With Chemotherapy, or Nivolumab in Combination With Ipilimumab, in Advanced EGFR-Mutant or ALK-Rearranged NSCLC
ClinicalTrials.gov study NCT03256136. IPD Sharing: NO. Countries: 1. Publications: 0.
T790M Mutation on ctDNA in Patients With NSCLC After EGFR-TKI Failure
ClinicalTrials.gov study NCT02418234. IPD Sharing: Not stated. Countries: 1. Publications: 0.
The Study Observes Afatinib as First-line Treatment in Patients With Epidermal Growth Factor Receptor (EGFR) Mutation-positive Advanced Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT04206787. IPD Sharing: YES. Countries: 1. Publications: 0.
Afatinib in Patients With Non Small Cell Lung Cancer (NSCLC) With Epidermal Growth Factor Receptor (EGFR) Mutations
ClinicalTrials.gov study NCT02044380. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Osimertinib With or Without Bevacizumab for EGFR- Mutant Non-small Cell Lung Cancer With Leptomeningeal Metastasis
ClinicalTrials.gov study NCT04148898. IPD Sharing: NO. Countries: 0. Publications: 10.
Afatinib Treatment for Patients With EGFR Mutation Positive NSCLC Who Are Age 70 or Older
ClinicalTrials.gov study NCT02514174. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Testing Afatinib as Potentially Targeted Treatment in Cancers With EGFR Genetic Changes (MATCH - Subprotocol A)
ClinicalTrials.gov study NCT06385483. IPD Sharing: YES. Countries: 1. Publications: 0.
An Open Label Trial of Afatinib (Giotrif) in Treatment-naive (1st Line) or Chemotherapy Pre-treated Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) Harboring EGFR Mutat
ClinicalTrials.gov study NCT01853826. IPD Sharing: YES. Countries: 11. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.